Chronic inflammatory demyelinating polyneuropathy: A 6-year retrospective clinical study of a hospital-based population

Journal of Clinical Neuroscience

Volumn 14, Issue 3, 2007, Pages 229-235

  Rentzos, M ^a   Anyfanti, C ^a   Kaponi, A ^a   Pandis, D ^a   Ioannou, M ^a   Vassilopoulos, D ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chronic inflammatory demyelinating polyneuropathy (CIDP); Clinical variability; Treatment response

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; DISEASE COURSE; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LABORATORY TEST; MALE; NEUROIMAGING; NEUROLOGY; NEUROPATHY; PLASMAPHERESIS; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; BIOPSY; DEMYELINATING DISEASES; FEMALE; GREECE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL CONDUCTION; PLASMA EXCHANGE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33846378446     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.11.001     Document Type: Article

References (40)

1. Barohn R.J., Kissel J.T., Warmolts J.R., et al. Chronic inflammatory demyelinating polyneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46 (1989) 878-888
2. Cornblath D.R., Asbury A.K., Albers J.W., et al. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41 (1991) 617-618
3. Gorson K.C., Allam G., and Ropper A.H. Chronic inflammatory demyelinating polyneuropathy:clinical features and response in treatment in 67 consecutive patients with and without gammopathy. Neurology 48 (1997) 321-328
4. Hughes R.A.C., Sanders E., Hall S., et al. Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 49 (1989) 612-616
5. Rotta F.T., Sussman A.T., Bradley W.G., et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 173 (2000) 129-139
6. Bouchard C., Lacroix C., Plante V., et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52 (1999) 498-503
7. Lunn M.P.T., Manji H., Choudhary P.P., et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in southeast England. J Neurol Neurosurg Psychiatry 66 (1999) 677-680
8. Sander H.W., and Latov N. Research criteria for defining patients with CIDP. Neurology 60 Suppl.3 (2003) S8-S15
9. Dyck P., Lais A.C., Ohta M., et al. Chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc 50 (1975) 621-637
10. McCombe P.A., Pollard J.D., and McLeod J.G. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain 110 (1987) 1617-1630
11. Waddy H.M., Misra V.P., King R.H.M., et al. Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions. J Neurol 236 (1989) 400-405
12. Mendell J.R., Kolkin S., Kissel J.T., et al. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyneuropathy. Neurology 37 (1987) 1291-1294
13. Rubin M., Karpati G., and Carpenter S. Combined central and peripheral myelinopathy. Neurology 37 (1987) 1287-1290
14. Stewart J.D., McKelvey R., Durcan L., et al. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci 142 (1996) 59-64
15. Dalakas M.C., and Engel W.K. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 9 Suppl. (1981) 134-145
16. Hafer-Macko C.E., Sheikh K.A., Li C.Y., et al. Immune attack on the surface on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39 (1996) 625-635
17. Hahn A.F. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology 51 Suppl.5 (1998) S16-S21
18. Hartung H.P., Willison H., Jung S., et al. Autoimmune responses in peripheral nerve. Springer Semin Immunopathol 18 (1996) 97-123
19. Harvey G.K., Pollard J.D., Schiindheim K., et al. Chronic experimental allergic neuritis. An electrophysiological study in the rabbit. J Neurol Sci 81 (1987) 215-225
20. Kimura K., Nezu A., Kimura S., et al. A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy. Neuropediatrics 29 (1998) 108-112
21. Sempere A.P., Claveria L.E., Cruz-Martinez A., et al. Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 3 (1996) 397-398
22. Jann S., Beretta S., and Bramerio M.A. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment. Muscle Nerve 32 (2005) 351-356
23. Cocito D., Durelli L., and Isoardo G. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia. Acta Neurol Scand 108 (2003) 274-280
24. Katz J.S., Saperstein D.S., Gonset G., et al. Distal acquired demyelinating polyneuropathy. Neurology 54 (2000) 615-620
25. Tagawa Y., Yuki N., and Hirata K. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy. Muscle Nerve 23 (2000) 895-899
26. Smith I.S. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia. Brain 117 (1994) 949-957
27. Simmons Z., Albers J.W., Bromberg M.B., et al. Presentation and initial clinical course in patients with chronic inflammatory polyneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 43 (1993) 2202-2209
28. Simmons Z., Albers J.W., Bromberg M.B., et al. Long-term follow-up of patients with chronic inflammatory polyneuropathy, without and with monoclonal gammopathy. Brain 119 (1996) 1055-1066
29. Gosselin S., Kyle R.A., and Dyck P.J. Neuropathy associated with monoclonal gammopathies of uncertain significance. Ann Neurol 30 (1991) 54-61
30. Dyck P.J., O'Brien P.C., Oviat K.F., et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11 (1982) 136-141
31. Hahn A.F., Bolton C.F., Pilay N., et al. Plasma exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 119 (1996) 1055-1066
32. Dyck P.J., Litchy W.J., Kratz K.M., et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory polyradiculoneyropathy. Ann Neurol 36 (1994) 838-845
33. Mendell J.R., Baroh R.J., Freimer M.L., et al. Randomized controlled trial of IVIg in untreated chronic inflammatory polyradiculoneuropathy. Neurology 56 (2001) 445-449
34. Albers J.W., and Kelly Jr. J.J. Acquired demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 12 (1989) 435-451
35. Hughes R., Bensa S., Willison H.J., et al. Randomized controlled trial of intravenous immunoglobulin versus prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50 (2001) 195-201
36. Nicolas G., Maisonobe T., Le Forestier N., et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 25 (2002) 26-30
37. Saperstein D.S., Katz J.S., Amato A.A., et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24 (2001) 311-324
38. Thaisetthawatkul P., Logigian E.L., and Herrmann D.N. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 59 (2002) 1526-1532
39. Van den Bergh P., and Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 29 (2004) 565-574
40. Magda P., Latov N., Brannagan T.H., et al. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 60 (2003) 1755-1759